✦ LIBER ✦

A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel® + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults

✍ Scribed by Issaka Sagara; Ruth D. Ellis; Alassane Dicko; Mohamed B. Niambele; Beh Kamate; Ousmane Guindo; Mahamadou S. Sissoko; Michael P. Fay; Merepen A. Guindo; Ousmane Kante; Renion Saye; Kazutoyo Miura; Carole Long; Gregory E.D. Mullen; Mark Pierce; Laura B. Martin; Kelly Rausch; Amagana Dolo; Dapa A. Diallo; Louis H. Miller; Ogobara K. Doumbo

Book ID: 116962178
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 358 KB
Volume: 27
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2009.10.087

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 1 safety and immunogenicity trial

Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adults

✍ Mark A. Pierce; Ruth D. Ellis; Laura B. Martin; Elissa Malkin; Eveline Tierney; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 330 KB

A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel®&#xa0;+&#xa0;CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults

A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel® + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults